HARROW, INC. — Director's Dealing 2010

Oct 22, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2010-10-20

Reporting Person: BONFIGLIO JOHN N (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-20	Restricted Common Stock	A	50000	$.80	Acquired	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-20	Stock option (right to buy)	$.80	A	400000	Acquired	2020-10-20	Common Stock (400000)	Direct

Footnotes

F1: Twenty-five percent of the shares subject to this grant vest immediately, with the balance vesting in equal monthly installments over the next 36 months, commencing November 20, 2010, subject to continuous service. An additional ten percent of the shares subject to this grant shall vest upon the closing of a qualified transaction.

F2: Twenty-five percent of the shares subject to the option grant vest immediately, with the balance vesting in equal monthly installments over the next 36 months, commencing November 20, 2010, subject to continuous service. An additional ten percent of the shares subject to this option grant shall vest upon the closing of a qualified transaction.